Increasing Use of the Vaccine Against Herpes Zoster/Shingles at NYULMC and Bellevue Hospital

NYU Langone Health

Status: Completed

Conditions: Herpes Zoster

Treatments: Other: Choosing to receive the vaccine

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT01483378

11-02029

Details and patient eligibility

About

The purpose of this study is to determine if vaccination rate of eligible patients at a major urban public hospital will increase by having ophthalmologists screen patients for eligibility and a nurse administer the vaccine in the General Eye Clinic.

Full description

Patient vaccination behaviors will be assessed after 100 doses of the Zostavax vaccine are provided to underserved patients screened by ophthalmologists at the General Eye Clinic at a public hospital that does not normally provide the vaccine. A nurse will be at the clinic to administer the vaccine. Patients will be contacted by phone 1 month later and seen within 3 months in the Eye Clinic to determine whether there were any side effects.

Enrollment: 170 patients

Sex: All

Ages: 60+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• 60 years of age or older
• Absence of evidence of immune compromise in the medical record
• Ability to speak and read English, Spanish or Chinese and give informed consent

Exclusion criteria

• Vulnerable patients, including the cognitively impaired, prisoners and employee
• FDA contraindications for Zostavax vaccine

Trial design

Primary purpose: Health Services Research

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

170 participants in 2 patient groups

Subjects who received the vaccine

Other group

Description:

Patients in this arm were eligible for the herpes zoster vaccine and chose to receive it.

Treatment:

Other: Choosing to receive the vaccine

Subjects who declined the vaccine

No Intervention group